Skip to main content
SpringerLink
Log in

Preparation of Nuflein - an Alkaloid from the Yellow Waterlily Nuphar Lutea - and its Cytotoxic Action on Cultures of Normal and Tumorous Human Cells

  • MEDICINAL PLANTS
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

The alkaloid from the yellow waterlily nuflein, whose preparation is described here, has cytotoxic activity against HeLa cervical cancer tumor cells. Suppression of the viability of normal fibroblasts requires nuflein concentrations 67 times greater than suppression of the viability of the same number of HeLa tumor cells. Cytotoxic activity is mediated by induction of the mitochondrial apoptosis pathway, as nuflein induces opening of mitochondrial pores and release of cytochrome c, which activates caspases. Nuflein also inhibits cellular energy generation due to uncoupling of oxidative phosphorylation in mitochondria and inhibition of mitochondrial respiration. The cytotoxic action of nuflein has been suggested to result from the properties of the sulfur atom in the thioether bond in the pharmacophore molecule. Utilization of the chemical properties of nuflein, allowing its steric structure to be “tuned,” may lead to the creation of a whole series of probes with different activities directed at modifying or inhibiting biologically important thiols. The greater selectivity of the antiproliferative activity of nuflein in relation to tumor cells as compared with the known antitumor substance cisplatin points to a specific antitumor nature for the activity of nuflein.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.

Similar content being viewed by others

References

  1. D. A. Murav′eva, I. A. Samylina, and G. P. Yakovlev, Farmacognosy [in Russian], Bukinist, Moscow (2002).

    Google Scholar 

  2. M. E. Perel′son, T. N. Il′inskaya, and O. N. Tolkachev, Khimiya Prirod. Soedin., 6, 768 – 770 (1975).

    Google Scholar 

  3. Russian Federation Patent RF 2292218 (2005).

  4. Russian Federation Patent RF 549965 (1975).

  5. A. Korotkov, N. Li, S. W, et al., Angew. Chem. Int. Ed. Engl., 54(36), 10,604 – 10,607 (2015).

  6. A. V. Semeikin, T. A. Fedotcheva, I. S. Levina, et al., Khim.-Farm. Zh., 48(6), 9 – 13 (2014); Pharm. Chem. J., 48(6), 363 – 367 (2014).

  7. T. A. Fedotcheva, N. L. Shimanovskii, A. G. Kruglov, et al., Biol. Membrany, 28(6), 1 – 8 (2011).

    Google Scholar 

  8. T. A. Fedotcheva, E. V. Odintsova, V. V. Banin, et al., Vestnik RONTs im. N. N. Blokhina RAMN , 4, 34 – 38 (2011).

    Google Scholar 

  9. F. Ciscato, M. Sciacovelli, G. Villano, et al., Oncotarget, 5(9), 2418 – 2427 (2014).

    Article  PubMed  Google Scholar 

  10. Y. Xu, H. B. Ma, Y. L. Fang, et al., Cell Signal., 31, 112 – 123 (2017); doi: https://doi.org/10.1016/j.cellsig.2017.01.004.

    Article  CAS  PubMed  Google Scholar 

  11. H. Matsuda, K. Yoshida, K. Miyagawa, et al., Bioorg. Med. Chem. Let., 16(6), 1567 – 1573 (2006).

    Article  CAS  Google Scholar 

  12. S. Okamura, E. Nishiyama, T. Yamazaki, et al., Biochim. Biophys. Acta, 1850(6), 1245 – 1252 (2015); doi: https://doi.org/10.1016/j.bbagen.2015.02.012.

    Article  CAS  PubMed  Google Scholar 

  13. J. Ozer, N. Eisner, E. Ostrozhenkova, et al., Cancer Biol. Ther., 8(19), 1860 – 1868 (2009).

    Article  CAS  PubMed  Google Scholar 

  14. N. Tada, D. J. Jansen, M. P. Mower, et al., ACS Cent. Sci., 2(6), 401 – 408 (2016); doi: https://doi.org/10.1021/acscentsci.6b00113.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Science Research Laboratory of Molecular Pharmacology, N. I. Pirogov Russian National Medical Research University, Russian Ministry of Health, Moscow, Russia

    T. A. Fedotcheva & N. L. Shimanovskii

  2. All-Russian Institute of Medicinal and Aromatic Herbs, Moscow, Russia

    T. A. Fedotcheva, O. P. Sheichenko, V. V. Anufrieva & V. I. Sheichenko

  3. Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino, Moscow District, Russia

    N. I. Fedotcheva

Authors
  1. T. A. Fedotcheva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O. P. Sheichenko
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. V. Anufrieva
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. V. I. Sheichenko
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. I. Fedotcheva
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. N. L. Shimanovskii
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 51, No. 7, pp. 34 – 39, July, 2017.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fedotcheva, T.A., Sheichenko, O.P., Anufrieva, V.V. et al. Preparation of Nuflein - an Alkaloid from the Yellow Waterlily Nuphar Lutea - and its Cytotoxic Action on Cultures of Normal and Tumorous Human Cells. Pharm Chem J 51, 590–595 (2017). https://doi.org/10.1007/s11094-017-1658-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-017-1658-4

Keywords

Search

Navigation